BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
160 results:

  • 1. Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study.
    Wei G; Zhao Y; Feng S; Yuan J; Xu G; Lv T; Yang J; Kong L; Yang J
    BMC Cancer; 2024 May; 24(1):558. PubMed ID: 38702621
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.
    Mittal K; Cooper GW; Lee BP; Su Y; Skinner KT; Shim J; Jonus HC; Kim WJ; Doshi M; Almanza D; Kynnap BD; Christie AL; Yang X; Cowley GS; Leeper BA; Morton CL; Dwivedi B; Lawrence T; Rupji M; Keskula P; Meyer S; Clinton CM; Bhasin M; Crompton BD; Tseng YY; Boehm JS; Ligon KL; Root DE; Murphy AJ; Weinstock DM; Gokhale PC; Spangle JM; Rivera MN; Mullen EA; Stegmaier K; Goldsmith KC; Hahn WC; Hong AL
    Commun Biol; 2024 Apr; 7(1):426. PubMed ID: 38589567
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Interaction between anemia and hyperuricemia in the risk of all-cause mortality in patients with chronic kidney disease.
    Lu Z; Lu F; Zhang R; Guo S
    Front Endocrinol (Lausanne); 2024; 15():1286206. PubMed ID: 38586465
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Postoperative outcomes of transperitoneal versus retroperitoneal robotic partial nephrectomy: a propensity-score matched comparison focused on patient mobilization, return to bowel function, and pain.
    Bertolo R; Ditonno F; Veccia A; De Marco V; Migliorini F; Porcaro AB; Rizzetto R; Cerruto MA; Autorino R; Antonelli A;
    J Robot Surg; 2024 Feb; 18(1):96. PubMed ID: 38413473
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Value of Dual-Energy Computed Tomography-Based Radiomics in the Evaluation of Interstitial Fibers of Clear Cell Renal Carcinoma.
    Bing X; Wang N; Li Y; Sun H; Yao J; Li R; Li Z; Ouyang A
    Technol Cancer Res Treat; 2024; 23():15330338241235554. PubMed ID: 38404055
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
    Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
    Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multiple factors influence decision making for the surgical treatment in patients with renal cell carcinoma.
    Kröger Dahlin BI; Hlodan J; Ghaffarpour R; Ljungberg B
    Scand J Urol; 2024 Feb; 59():26-30. PubMed ID: 38358280
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy.
    Xu K; Li D; Qian J; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Sun H; Shi G; Dai H; Liu H
    Front Immunol; 2024; 15():1288240. PubMed ID: 38292868
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and birc3 in clear cell renal cell carcinoma.
    Wei K; Zhang X; Yang D
    PeerJ; 2023; 11():e16643. PubMed ID: 38130918
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Stereotactic radiosurgery of brain metastases: a retrospective study.
    Gruber I; Weidner K; Treutwein M; Koelbl O
    Radiat Oncol; 2023 Dec; 18(1):202. PubMed ID: 38115009
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
    Bauer TM; Santoro A; Lin CC; Garrido-Laguna I; Joerger M; Greil R; Spreafico A; Yau T; Goebeler ME; Hütter-Krönke ML; Perotti A; Juif PE; Lu D; Barys L; Cremasco V; Pelletier M; Evans H; Fabre C; Doi T
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030303
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Stentless florence robotic intracorporeal neobladder (FloRIN), a feasibility prospective randomized clinical trial.
    Lambertini L; Di Maida F; Cadenar A; Nardoni S; Grosso AA; Valastro F; Spinelli P; Fantechi R; Tuccio A; Vittori G; Mari A; Masieri L; Minervini A
    Eur J Surg Oncol; 2024 Jan; 50(1):107259. PubMed ID: 38011784
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Protein Arginine Methyltransferases Refine the Classification of Clear Cell Renal Cell Carcinoma with Distinct Prognosis and Tumor Microenvironment Characteristics.
    Ye S; Tian X; Anwaier A; Wei S; Liu W; Su J; Zhu S; Dai B; Gu J; Qu Y; Xu W; Zhang H; Ye D
    Int J Biol Sci; 2023; 19(14):4552-4570. PubMed ID: 37781030
    [No Abstract]    [Full Text] [Related]  

  • 14. Pre-operative Plasma Fibrinogen Level as a Potential Predictor of Pathological T3 Upstaging in Clinically Localized Renal Cell Carcinoma.
    Sekito S; Tanaka S; Kitano G; Kato M; Ogura Y; Kojima T
    Anticancer Res; 2023 Sep; 43(9):4229-4235. PubMed ID: 37648302
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Development and validation of a prognostic model for patients with sepsis in intensive care unit].
    Jiang Z; Wang H; Wang S; Guan C; Qu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):800-806. PubMed ID: 37593856
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex.
    Klonowska K; Giannikou K; Grevelink JM; Boeszoermenyi B; Thorner AR; Herbert ZT; Afrin A; Treichel AM; Hamieh L; Kotulska K; Jozwiak S; Moss J; Darling TN; Kwiatkowski DJ
    Am J Hum Genet; 2023 Jun; 110(6):979-988. PubMed ID: 37141891
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The shrinkage effect of formalin on renal cell carcinoma: Does it change the stages.
    Akgul M; Arslan AI; Yazici C; Altin E; Oznur M
    J Pak Med Assoc; 2022 Nov; 72(11):2175-2179. PubMed ID: 37013281
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).
    Boulenger de Hauteclocque A; Ferrer L; Ambrosetti D; Ricard S; Bigot P; Bensalah K; Henon F; Doumerc N; Méjean A; Verkarre V; Dariane C; Larré S; Champy C; de La Taille A; Bruyère F; Rouprêt M; Paparel P; Droupy S; Fontenil A; Patard JJ; Durand X; Waeckel T; Lang H; Lebâcle C; Guy L; Pignot G; Durand M; Long JA; Charles T; Xylinas E; Boissier R; Yacoub M; Colin T; Bernhard JC
    BJU Int; 2023 Aug; 132(2):160-169. PubMed ID: 36648124
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification and validation of ubiquitin-proteasome system related genes as a prognostic signature for papillary renal cell carcinoma.
    Zhang X; Liu X; Xiong R; An HX
    Aging (Albany NY); 2022 Nov; 14(23):9599-9616. PubMed ID: 36385010
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparative analysis of surgical and oncologic outcomes of robotic, laparoscopic and open radical nephrectomy with venous thrombectomy: a propensity-matched cohort study.
    Zhang Y; Bi H; Yan Y; Liu Z; Wang G; Song Y; Zhang S; Liu C; Ma L
    Int J Clin Oncol; 2023 Jan; 28(1):145-154. PubMed ID: 36380158
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.